|
Cardiology
Clinical safety and effectiveness of the Genoss drug-eluting stent in real-world clinical practice
Young Jin Youn, Jun-Won Lee, Sung Gyun Ahn, Seung-Hwan Lee, Junghan Yoon, Jae Hyoung Park, Sang-Yong Yoo, Woong Chol Kang, Nam Ho Lee, Ki Hwan Kwon, Joon Hyung Doh, Sang-Wook Lim, Yang Soo Jang, Dong Woon Jeon, Jung Ho Heo, Woong Gil Choi, Sungsoo Cho, Bong-Ki Lee, Hyonju Jeong, Bum-Kee Hong, Hyun-Hee Choi
Korean J Intern Med. 2023;38(5):683-691. Published online July 7, 2023
Background/Aims: The Genoss DES™ is a novel, biodegradable, polymer-coated, sirolimus-eluting stent with a cobalt- chromium stent platform and thin strut. Although the safety and effectiveness of this stent have been previously investigated, real-world clinical outcomes data are lacking. Therefore,..
|
|
|
Reference diameter and characteristics of the distal radial artery based on ultrasonographic assessment
Jun-Won Lee, Jung-Woo Son, Tae-Hwa Go, Dae Ryong Kang, Sang Jun Lee, Se Eun Kim, Dong-Hyuk Cho, Young Jun Park, Young Jin Youn, Min-Soo Ahn, Sung Gyun Ahn, Jang-Young Kim, Byung-Su Yoo, Junghan Yoon, Seung-Hwan Lee
Korean J Intern Med. 2022;37(1):109-118. Published online December 29, 2021
Background/Aims: While distal radial artery (DRA) access is increasingly being used for diagnostic coronary angiography, limited information is available regarding DRA size. We aimed to determine the DRA reference diameters of Korean patients and identify the predictors of DRA diameter < 2.3 mm.
Me..
|
|
|
Chronic venous insufficiency and varicose veins of the lower extremities
Young Jin Youn, Juyong Lee
Korean J Intern Med. 2019;34(2):269-283. Published online October 26, 2018
Chronic venous insufficiency (CVI) of the lower extremities manifests itself in various clinical spectrums, ranging from asymptomatic but cosmetic problems to severe symptoms, such as venous ulcer. CVI is a relatively common medical problem but is often overlooked by healthcare providers because of ..
|
|
|
A pharmacodynamic study of the optimal P2Y12 inhibitor regimen for East Asian patients with acute coronary syndrome
Ji Hyun Lee, Sung Gyun Ahn, Bonil Park, Sang Wook Park, Yong Seok Kang, Jun-Won Lee, Young Jin Youn, Min-Soo Ahn, Jang-Young Kim, Byung-Su Yoo, Seung-Hwan Lee, Junghan Yoon
Korean J Intern Med. 2015;30(5):620-628. Published online August 27, 2015
Background/Aims: Newer P2Y12 inhibitors, such as prasugrel and ticagrelor, have greater antiplatelet efficacy but may increase the risk of bleeding. In this study, we compared the pharmacodynamic efficacy of prasugrel and ticagrelor in East Asian patients with acute coronary syndrome (ACS..
|
|
|
